对心力衰竭患者静脉注射铁疗法的指南的实施
Milou Gamage1, Aristomenis Manouras1,2,3, Camilla Hage1,2,3
1Heart and Vascular Center, Karolinska University Hospital, Stockholm, Sweden.
ESC heart failure
|June 21, 2025
概括
在心力衰竭患者中,54%的人接受了缺铁查,查的个体显示疾病更为晚期. 这突显了国家注册表在改善患者护理和治疗坚持方面的潜力.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 临床研究 临床研究
背景情况:
- 缺铁在心力衰竭 (HF) 中很常见,并影响患者的结果.
- 2021年ESC指南建议在HF患者中查和治疗铁缺乏症.
- 这些指南的实施需要在临床实践中进行评估.
研究的目的:
- 在卡罗林斯卡大学医院评估遵守2021年ESC铁缺乏症查和治疗心力衰竭患者的指南.
- 为了确定查与未查患者的特征.
主要方法:
- 从SwedeHF注册 (2021) 中对261名心力衰竭患者 (LVEF<50%,NYHAII-IV类) 的回顾性分析.
- 数据提取包括患者的特征,缺铁查,铁性碳素糖 (FCM) 给药,以及HF药物.
- 查 (n=141) 和未查患者的比较.
主要成果:
- 54%符合条件的心力衰竭患者接受了铁缺乏症查.
- 查患者的LVEF显著降低,NT-proBNP水平更高,糖尿病患病率更高.
- 被查的患者更有可能接受SGLT2抑制剂和循环利尿剂;那些接受IV铁治疗的人具有更高的NYHA类.
结论:
- 这项研究发现,54%的心力衰竭患者的射出分数减少或中等范围被选为缺铁.
- 被查的患者表现出更严重的HF,这表明医疗照顾和指导方针遵守程度增加.
- 国家质量注册表是监测结果和改善心力衰竭管理患者护理的有效工具.
相关概念视频
01:22Heart Failure VI: Adjunct Therapies
39
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
39
01:30Heart Failure VII: Nursing Interventions
147
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
147
01:30Heart Failure V: Medical Management
34
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
34
01:30Heart Failure IV: Classification and Diagnostic Evaluation
43
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
43
01:26Heart Failure Drugs: Inotropic Agents
745
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
745
01:20Rheumatic Heart Disease IV: Nursing Management
41
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
41